摘要
The purpose of this study was to use a kind of safe,long acting and reversible hormonal regimen for male contraception .The studied regimen was a subdermal insertion of a two rod implant (Sino implant, each rod containing 75 mg levenorgestrel LNG) in each subject's forearm, followed 3 weeks after by monthly injection of TU (Testosterone Undecanoate 250 mg) for 3 months. Eighteen weeks after implantation, the Sino implant was removed. There were altogether 16 male volunteers recruited in the entire research program. Among them 6 cases reached azoospermia; one case reached oligozoospermia (sperm density <3 million/ml); 5 cases' sperm density declined greatly, the lowest to be 5.7±1.3 million/ml; the other four cases' sperm density also declined, but remained within normal range (above 20 million/ml), the lowest to be 24.5±9.0 million/ml. The duration to reach azoospermia was 16.7±0.5 weeks. The duration to resume to normal range of sperm density was 8.2±2.5 weeks in the subjects with azoospermia and oligozoospermia. In the first two weeks after insertion the LNG release of Sino implant's mean serum LNG level was about 0.38 ng/ml, in the rest of the time the LNG levels in blood was rather constant about 0.24 ng/ml. Routine analyses of blood and urine, liver and kidney functions, and blood chemistry including those parameters (TG,TC,HDL C,LDL C) of lipid metabolism didn't change much throughout the research. All the subjects' libido and sex function were well kept. Clinical observation didn't show any other adverse effects during the research.
Ｒｅｓｅａｒｃｈｏｎｍａｌｅｃｏｎｔｒａｃｅｐｔｉｏｎｌａｇｓｆａｒｂｅｈｉｎｄｔｈａｎｔｈａｔｏｎｆｅｍａｌｅｃｏｎｔｒａｃｅｐｔｉｏｎ．Ｔｈｅｒｅｉｓｆｅｗｍａｌｅｈｏｒｍｏｎａｌｃｏｎｔｒａｃｅｐｔｉｖｅｔｈａｔｃｏｕｌｄｂｅｗｉｄｅｌｙｕｓｅ...
